Catalent, which operates a major pharmaceutical manufacturing plant in Blagrove in west Swindon, wants to use an empty building at its site for a new laboratory. Catalent’s planning application says: “The West Building redevelopment is to be developed in two phases to include two production lines. This report deals only with the production line known as Line 13. “Catalent not only supports skilled local jobs but also delivers treatments that make a real difference for people living with allergies. “We choose Swindon because of the skilled workforce, advanced capabilities, and the strong collaboration we’ve built here.